M1A.11
Lead-induced chronic gout, shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Lead-induced chronic gout, specifically affecting the shoulder, is a rare form of gout caused by long-term exposure to lead. Gout is a type of arthritis that results from the buildup of uric acid crystals in the joints. When lead accumulates in the body over time, it can interfere with normal metabolic processes, leading to joint inflammation and pain characteristic of gout. This condition is classified under ICD-10 code M1A.11 and highlights the impact of environmental toxins on musculoskeletal health. Recognizing this form of gout is essential for proper management and treatment, especially in individuals with known lead exposure.
Causes & Symptoms
Clinical Causes: Chronic exposure to lead from occupational sources such as mining, painting, or manufacturing. Environmental exposure to lead-based paints or contaminated water sources. Prolonged ingestion of lead-containing products or contaminated food. Accumulation of lead in the body over years, affecting various biochemical processes. Impaired renal function due to lead toxicity, leading to decreased uric acid excretion.
Key Symptoms: Persistent shoulder pain and stiffness, often worsening over time. Swelling and tenderness around the shoulder joint. Presence of tophi (urate crystal deposits) in or around the shoulder. Reduced range of motion and difficulty moving the shoulder. Possible signs of systemic lead toxicity, such as fatigue, anemia, or abdominal discomfort. Recurrent episodes of joint swelling and redness typical of gout attacks.
Diagnostic & Treatment
Diagnosis Path: Blood tests to check for elevated uric acid levels. Blood lead level testing to confirm lead exposure. Joint fluid analysis to identify urate crystals under microscopy. X-rays or imaging studies to detect joint damage or tophi. Assessment of renal function to evaluate lead's impact on the kidneys.
Treatment Protocols: Reducing or eliminating exposure to sources of lead. Medications to lower uric acid levels, such as allopurinol or febuxostat. Anti-inflammatory drugs to relieve joint pain and inflammation during gout attacks. Chelation therapy in cases of significant lead poisoning, under medical supervision. Supporting renal health through hydration and diet modifications. Regular monitoring of blood lead and uric acid levels to assess treatment effectiveness.
Clinical Advice & FAQs
Billing Guidance
Is M1A.11 a billable ICD-10 code?
Yes, M1A.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M1A.11?
Clinical documentation must specify the nature of Lead-induced chronic gout, shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference